retatrutide release date This weight-loss drug hasn't been approved by the FDA. Doctors are prescribing it anyway Retatrutide API (CAS 2381089-83-2)

Order Now Find More By Category

Most hormone clinics in Louisiana cannot make this claim

Typically 60-80% less than retail pharmaceutical pricing, making long-term treatment more financially feasible for many patients

On average, a clinical trial showed patients using Semaglutide GLP-1 for a year lost approximately 14.9% of their body weight

The BUD is typically 28 to 60 days from the compounding date, with many pharmacies defaulting to 28 days after first puncture for multi-dose vials

On physical exam, the patient had multiple 1-2 cm erythematous, scaly plaques located on the back, chest, and legs, some were excoriated with hemorrhagic crust (Figure 1)